Ilmarinen Mutual Pension Insurance’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-86,000
Closed -$59K 251
2020
Q4
$59K Hold
86,000
﹤0.01% 223
2020
Q3
$194K Hold
86,000
﹤0.01% 226
2020
Q2
$308K Hold
86,000
﹤0.01% 216
2020
Q1
$272K Hold
86,000
0.01% 211
2019
Q4
$180K Buy
+86,000
New +$224K ﹤0.01% 204

Other funds holding BMY.RT

Ilmarinen Mutual Pension Insurance's BMY.RT Position: Q1 2021 in Review

Ilmarinen Mutual Pension Insurance sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 86,000 shares — an estimated $59K sold.

Ilmarinen Mutual Pension Insurance first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $308K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Ilmarinen Mutual Pension Insurance reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Ilmarinen Mutual Pension Insurance sold 86,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $59K.
  • Ilmarinen Mutual Pension Insurance first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Ilmarinen Mutual Pension Insurance's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $308K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Ilmarinen Mutual Pension Insurance's 13F filing for Q1 2021, filed 23 Apr 2021.